I already have the full Guyton and Hall content on Peptic Ulcer from the previous turn, including etiology and treatment. Let me compose the short note directly.
Short Note: Peptic Ulcer - Etiology and Physiological Basis of Treatment
(Guyton and Hall Textbook of Medical Physiology, 4th South Asia Edition - Chapter 67)
Definition
A peptic ulcer is an excoriated area of stomach or intestinal mucosa caused principally by the digestive action of gastric juice or upper small intestinal secretions.
Common Sites
Most frequent sites: within a few centimeters of the pylorus, along the lesser curvature of the antral stomach, lower esophagus (due to reflux), and at a surgical gastrojejunostomy (marginal ulcer).
Etiology
Peptic ulceration results from an imbalance between aggressive factors (acid/pepsin secretion) and defensive factors (mucosal barrier + neutralization). A peptic ulcer forms when either (1) excess acid and pepsin are secreted or (2) the mucosal barrier is broken down.
Specific Causes:
1. Helicobacter pylori Infection (>75% of cases)
- Chronic infection of the terminal gastric and initial duodenal mucosa
- H. pylori penetrates the mucosal barrier by physically burrowing through it and by releasing ammonium, which:
- Liquefies the protective mucus barrier
- Stimulates excess HCl secretion
- Exposed epithelium is then digested by gastric acid-pepsin, causing ulceration
- Infection persists lifelong unless eradicated by antibacterial therapy
2. Excess Acid Secretion
- Duodenal ulcer patients may have acid secretion up to twice normal
- Triggers: H. pylori, psychological/psychic disturbances (stress stimulates vagal and gastric gland activity)
3. Other Predisposing Factors
| Factor | Mechanism |
|---|
| Smoking | Increased nervous stimulation of gastric secretory glands |
| Excess alcohol | Directly breaks down the mucosal barrier |
| Aspirin/NSAIDs | Break down the mucosal barrier (inhibit prostaglandin-mediated protection) |
| Poor blood supply | Reduces mucosal resistance to digestion |
| Poor mucus secretion | Impairs the protective mucus coating |
Physiological Basis of Treatment
Since the discovery that most peptic ulcers have a bacterial infectious basis, treatment is directed at two targets:
1. Eradication of H. pylori - Antibacterial Therapy
- Rationale: H. pylori is the root cause in >75% of cases. Eliminating the infection removes the primary source of mucosal barrier breakdown and excess acid stimulation.
- Antibiotics (e.g., amoxicillin, clarithromycin) are used in combination regimens to eradicate the organism permanently.
2. Suppression of Acid Secretion
Three classes of acid-suppressants are described in Guyton and Hall:
(a) H₂-Receptor Blockers (e.g., Ranitidine)
- Physiological basis: Histamine acts on gastric gland H₂ receptors to stimulate HCl secretion by parietal cells
- Ranitidine blocks H₂ receptors, reducing gastric acid secretion by 70-80%
- This allows the mucosal barrier to recover and ulcer healing to proceed
(b) Proton Pump Inhibitors (PPIs)
- Physiological basis: Parietal cells secrete H⁺ into the gastric lumen via H⁺-K⁺ ATPase (the proton pump)
- PPIs block H⁺-K⁺ ATPase, directly and potently reducing acid secretion by parietal cells
- Most effective class of acid suppressants currently available
(c) Potassium-Competitive Acid Blockers (e.g., Vonoprazan)
- Physiological basis: Bind to the potassium-binding region of the proton pump (H⁺-K⁺ ATPase), competitively inhibiting it
- Suppress acid secretion effectively and are used in recent years as an alternative to classical PPIs
3. Surgical Treatment (Severe/Refractory Cases)
When conservative therapy fails or complications arise (e.g., massive bleeding from ulcer), surgical measures include:
- Partial gastrectomy - removal of part of the stomach to reduce acid-secreting parietal cell mass
- Vagotomy - cutting the two vagus nerves that supply parasympathetic stimulation to gastric glands, thereby reducing the cephalic phase of gastric acid secretion
Summary Table
| Treatment | Physiological Target | Mechanism |
|---|
| Antibiotics | H. pylori infection | Eradicate bacteria; restore mucosal barrier |
| H₂-blockers (ranitidine) | H₂ receptors on parietal cells | Block histamine-driven HCl secretion (↓70-80%) |
| PPIs | H⁺-K⁺ ATPase (proton pump) | Block the final step of H⁺ secretion |
| Potassium-competitive acid blockers (vonoprazan) | K⁺-binding site of proton pump | Competitive inhibition of acid secretion |
| Vagotomy | Vagus nerve (parasympathetic) | Reduce cephalic phase stimulation of gastric glands |
| Partial gastrectomy | Parietal cell mass | Reduce total acid-secreting capacity |
(Guyton and Hall Textbook of Medical Physiology, 4th South Asia Edition, Chapter 67, pp. 824-825)